End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.65 USD | +1.43% | +1.91% | +4.41% |
09:57am | Kenvue Prices Secondary Common Stock Offering | MT |
14/05 | Transcript : Johnson & Johnson Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM |
Sales 2024 * | 8.84TCr 7,37500Cr | Sales 2025 * | 9.08TCr 7,57600Cr | Capitalization | 36TCr 30,40300Cr |
---|---|---|---|---|---|
Net income 2024 * | 2.2TCr 1,83900Cr | Net income 2025 * | 2.31TCr 1,92700Cr | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 699.71Cr 58TCr | Net cash position 2025 * | 2.11TCr 1,75900Cr | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 1,31,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.43% | ||
1 week | +1.91% | ||
Current month | +3.40% | ||
1 month | -0.93% | ||
3 months | -2.74% | ||
6 months | +9.01% | ||
Current year | +4.41% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 10.65 | +1.43% | 296 |
13/24/13 | 10.5 | +0.96% | 333 |
10/24/10 | 10.4 | -0.95% | 349 |
09/24/09 | 10.5 | +0.96% | 201 |
08/24/08 | 10.4 | -0.48% | 605 |
End-of-day quote Buenos Aires S.E., May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.26% | 59TCr | |
+19.41% | 33TCr | |
+5.08% | 29TCr | |
+15.51% | 24TCr | |
+10.04% | 21TCr | |
-7.08% | 20TCr | |
+9.24% | 17TCr | |
-0.47% | 16TCr | |
+1.26% | 12TCr |
- Stock Market
- Equities
- JNJ Stock
- JNJD Stock